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本研究以创伤弧菌 MEP途径中的关键酶 DXS及 DXR为研究对象，通过分
子生物学方法，构建了创伤弧菌 DXS 和 DXR 蛋白的表达载体；优化了蛋白的
表达条件，获得了可溶性表达的 VvDXS 和 VvDXR 蛋白；采用亲和层析法对表
达产物 VvDXS和 VvDXR进行了纯化，获得了两个具有天然酶活性的可溶性蛋
白；建立了 VvDXS 和 VvDXR 的酶活测定体系，并对反应温度、缓冲液 pH、底
物浓度、反应酶量等条件进行了优化；在上述基础上建立了 VvDXR 抑制剂的筛
选体系，构建了靶向 VvDXS 和 VvDXR的 VvDXS-VvDXR抑制剂高通量筛选模
型并评价了模型的可行性；应用 VvDXS-VvDXR 偶联模型对 57 个化合物进行了


















Vibriosis is one of the most important bacterial diseases of aquatic animals,
which brings great economic losses to aquaculture in China every year. And a large
number of antibiotics were abused to treat bacterial diseases, which leads to the
occurrence of multidrug-resistant strains, making the diseases more difficult to control.
Hence, exploring new antibiotics targets and developing novel antibiotics become a
matter of maximum urgency.
Targeting biochemical pathways that exist in bacteria but not in humans, presents
an important strategy for antimicrobial drug design and development. One such
important pathway is the 2-C-methyl-D-erythritol-4-phosphate (MEP) pathway for
terpenoid biosynthesis. Since terpenoids cannot be acquired from the environment,
and pathogenic organisms rely exclusively on the MEP pathway for terpenoids and
humans do not, the enzymes of this route have been recently explored as new
therapeutic targets. The 1-deoxy-D-xylulose-5-phosphate synthase (DXS) catalyzes
the first, rate-limiting step of the MEP pathway and is also essential for thiamine and
pyridoxol biosynthesis in bacteria. The second committed step is catalyzed by
1-deoxy-Dxylulose-5-phosphate reductoisomerase (DXR). In conclusion, DXS and
DXR are alluring targets for the design of novel anti-infective drugs.
In this study, the key enzymes DXS and DXR in Vibrio vulnificus were
considered as research objects. DXS and DXR were expressed in plasmid pET-22b(+)
and purified by Ni2+ chelating affinity chromatography. And based on their enzyme
activity assays, a high-throughput screening model both target DXS and DXR were
finally been built and evaluated. Using this model, 57 compounds were screened, but
only one compound show inhibitory activity on DXR. However, the compound which
inhibit the activity of DXR need further separating and detecting, laying the
foundation for the discovering of the new antibacterial drugs.

















bp base pair 碱基对
HTS High-throughput screening 高通量筛选
Amp ampicillin 氨苄青霉素





APS ammonium persulfate 过硫酸铵
SDS sodium dodecyl sulfate 十二烷基硫酸钠
PAGE polyacrylamide gel electrophoresis 聚丙烯酰氨凝胶电泳
MVA mevalonate pathway 甲羟戊酸途径













Pyr pyruvic acid 丙酮酸
DTT dithiothreitol 二硫苏糖醇
TPP thiamine pyrophosphate 焦磷酸硫胺素
















NADP nicotinamide adenine dinucleotide phosphate 氧化型烟酰胺腺嘌呤二
核苷酸磷酸
TLC thin layer chromatography 薄层层析
OD optical density 光密度
PCR polymerase chain reaction 聚合酶链式反应
PMSF phenylmethanesulfonyl fluoride 苯甲基磺酰氟
IC50 half maximal inhibitory concentration 半抑制浓度













































































Table 1. Pathogenic vibrios and diseases caused by vibrio
病原菌 宿主 主要症状 流行范围
鳗弧菌 鳗鲡、牙鲆、香鱼等 败血症 世界范围
霍乱弧菌 香鱼 体表发炎、充血 日本















创伤弧菌 鳗鲡、对虾、石斑鱼 体表发炎、充血 中国、西班牙、日本
哈维氏弧菌 鲈鱼等海水鱼 体表发炎、充血 世界范围
杀鲑弧菌 鲑鱼 败血症 挪威、英国
副溶血弧菌 海水鱼类、对虾 体表发炎、充血 世界范围
拟态弧菌 石斑鱼、真鲷 体表发炎、充血 中国、日本
病海鱼弧菌 海水鱼类 败血症 世界范围
灿烂弧菌 大鲮鲆、海鲈 腹部肿胀、肠壁充血 西班牙、挪威
雀鲷弧菌 海水鱼类 体表发炎、充血 世界范围
鱼肠道弧菌 比目鱼 体表发炎、充血 日本
美人鱼弧菌 海豚、大鲮鲆 吻部和鳃盖充血发红 日本、西班牙
坎氏弧菌 牡蛎、鲈、对虾 脓毒败血症、红腿病 世界范围




































有很强的耐药性[30]；赵鲁宁等检测 38 株不同来源的鳗弧菌对 28 种抗生素敏感
性，结果显示菌株对林可霉素、夫西地酸、甲硝唑、阿莫西林、阿莫西林/克拉
维酸、苯唑西林、青霉素 7 种抗生素的耐药率为 100%，对红霉素、原始霉素、
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